OBIO insider transaction filings
Orchestra BioMed Holdings, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-11. Screen OBIO transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 18 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings by 2 insiders — 12,000 shares, $58,560 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings by 1 insider — 45,000 shares, $199,500 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 15,000 shares @ $4.94 ($74,100) by Sherman Darren, filed 2026-09-02.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Sherman Darren — See Remarks, Director | 4 | 1 leg · 2,000 sh · $10,660 | 3 legs · 45,000 sh · $199,500 | 1 |
| Hochman David P — See Remarks, Director | 2 | 1 leg · 10,000 sh · $47,900 | — | 2 |
| Fain Eric S — Director | 2 | — | — | 4 |
| Pacitti David — Director | 2 | — | — | 4 |
| Cleary Chris — Director | 2 | — | — | 3 |
| Mack John Prosper — Director | 2 | — | — | 3 |
| Connealy Pamela Ann — Director | 1 | — | — | 2 |
| Aiello Joshua — Principal Accounting Officer | 1 | — | — | 1 |
| Aryeh Jason — Director | 1 | — | — | 1 |
| Taylor Andrew Lawrence — Chief Financial Officer | 1 | — | — | 1 |
Recent Form 4 filings — Orchestra BioMed Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Hochman David P — See Remarks, Director | Tax withholding (F): 3,283 @ $5.81 · Tax withholding (F): 3,283 @ $5.81 | EDGAR |
| 2026-09-08 | 4 | Hochman David P — See Remarks, Director | Purchase (P): 10,000 @ $4.79 | EDGAR |
| 2026-09-02 | 4 | Sherman Darren — See Remarks, Director | Sale (S): 15,000 @ $4.94 | EDGAR |
| 2026-08-28 | 4 | Sherman Darren — See Remarks, Director | Tax withholding (F): 4,925 @ $5.26 · Purchase (P): 2,000 @ $5.33 | EDGAR |
| 2026-08-28 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Tax withholding (F): 3,076 @ $5.26 | EDGAR |
| 2026-08-28 | 4 | Aiello Joshua — Principal Accounting Officer | Tax withholding (F): 203 @ $5.26 | EDGAR |
| 2026-08-14 | 4 | Cleary Chris — Director | Tax withholding (F): 4,238 @ $4.42 | EDGAR |
| 2026-08-14 | 4 | Mack John Prosper — Director | Tax withholding (F): 4,885 @ $4.42 | EDGAR |
| 2026-08-14 | 4 | Fain Eric S — Director | Tax withholding (F): 5,145 @ $4.42 | EDGAR |
| 2026-08-14 | 4 | Pacitti David — Director | Tax withholding (F): 3,761 @ $4.42 | EDGAR |
| 2026-08-04 | 4 | Sherman Darren — See Remarks, Director | Sale (S): 15,000 @ $4.09 | EDGAR |
| 2026-07-02 | 4 | Sherman Darren — See Remarks, Director | Sale (S): 15,000 @ $4.27 | EDGAR |
| 2026-06-25 | 4 | Cleary Chris — Director | Tax withholding (F): 3,510 @ $0 · Grant/award (A): 42,553 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Mack John Prosper — Director | Grant/award (A): 34,653 @ $0 · Tax withholding (F): 3,510 @ $0 | EDGAR |
| 2026-06-25 | 4 | Connealy Pamela Ann — Director | Grant/award (A): 17,327 @ $0 · Grant/award (A): 21,277 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Pacitti David — Director | Grant/award (A): 17,327 @ $0 · Tax withholding (F): 3,784 @ $0 · Grant/award (A): 21,277 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Fain Eric S — Director | Grant/award (A): 17,327 @ $0 · Tax withholding (F): 4,261 @ $0 · Grant/award (A): 21,277 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Aryeh Jason — Director | Grant/award (A): 42,553 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Tax withholding (F): 36,352 @ $4.02 | EDGAR |
| 2026-06-12 | 4 | Hochman David P — See Remarks, Director | Tax withholding (F): 3,283 @ $4.02 · Tax withholding (F): 3,283 @ $4.02 | EDGAR |
| 2026-06-02 | 4 | Sherman Darren — See Remarks, Director | Sale (S): 15,000 @ $3.87 | EDGAR |
| 2026-06-02 | 4 | Hochman David P — See Remarks, Director | Purchase (P): 5,000 @ $3.83 | EDGAR |
| 2026-05-29 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Tax withholding (F): 3,076 @ $3.98 | EDGAR |
| 2026-05-29 | 4 | Sherman Darren — See Remarks, Director | Tax withholding (F): 4,925 @ $3.98 | EDGAR |
| 2026-05-20 | 4 | Aryeh Jason — Director | Purchase (P): 665 @ $3.75 | EDGAR |
| 2026-05-19 | 4 | Aryeh Jason — Director | Purchase (P): 8,971 @ $3.90 | EDGAR |
| 2026-05-19 | 4 | Hochman David P — See Remarks, Director | Purchase (P): 5,000 @ $3.77 | EDGAR |
| 2026-05-18 | 4 | Fain Eric S — Director | Purchase (P): 20,000 @ $4.13 | EDGAR |
| 2026-04-29 | 4 | RTW INVESTMENTS, LP — 10% owner WONG RODERICK — 10% owner | Option exercise/expiry (X): 1,250,032 @ $0.00 · Sale (S): 32 @ $4.13 · Option exercise/expiry (X): 1,250,032 (derivative) @ $2.75 | EDGAR |
| 2026-03-27 | 4 | Aiello Joshua — Principal Accounting Officer | Tax withholding (F): 241 @ $4.57 | EDGAR |
| 2026-03-27 | 4 | Sherman Darren — See Remarks, Director | Tax withholding (F): 33,317 @ $4.57 | EDGAR |
| 2026-03-27 | 4 | Hochman David P — See Remarks, Director | Tax withholding (F): 32,438 @ $4.57 | EDGAR |
| 2026-03-16 | 4 | Hochman David P — See Remarks, Director | Purchase (P): 10,000 @ $4.29 | EDGAR |
| 2026-02-13 | 4 | Aiello Joshua — Principal Accounting Officer | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Grant/award (A): 181,000 @ $0 | EDGAR |
| 2026-02-13 | 4 | Sherman Darren — See Remarks, Director | Grant/award (A): 397,000 @ $0 | EDGAR |
| 2026-02-13 | 4 | Hochman David P — See Remarks, Director | Grant/award (A): 504,000 @ $0 | EDGAR |
| 2026-02-06 | 4 | Cleary Chris — Director | Tax withholding (F): 676 @ $3.71 | EDGAR |
| 2026-02-06 | 4 | Sherman Darren — See Remarks, Director | Grant/award (A): 34,974 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Aiello Joshua — Principal Accounting Officer | Tax withholding (F): 241 @ $4.31 | EDGAR |
| 2026-01-02 | 4 | Sherman Darren — See Remarks, Director | Tax withholding (F): 5,588 @ $4.31 | EDGAR |
| 2026-01-02 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Tax withholding (F): 3,452 @ $4.31 | EDGAR |
| 2025-12-12 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Tax withholding (F): 8,670 @ $4.67 | EDGAR |
| 2025-12-12 | 4 | Hochman David P — See Remarks, Director | Tax withholding (F): 40,355 @ $4.67 · Tax withholding (F): 3,283 @ $4.67 | EDGAR |
| 2025-11-26 | 4 | Taylor Andrew Lawrence — Chief Financial Officer | Tax withholding (F): 3,071 @ $5.35 | EDGAR |
| 2025-11-26 | 4 | Sherman Darren — See Remarks, Director | Tax withholding (F): 40,340 @ $5.35 | EDGAR |
| 2025-11-17 | 4 | Hochman David P — See Remarks, Director | Purchase (P): 5,000 @ $4.07 | EDGAR |
| 2025-11-14 | 4 | Hochman David P — See Remarks, Director | Tax withholding (F): 3,283 @ $4.18 · Tax withholding (F): 3,283 @ $4.18 | EDGAR |
| 2025-09-19 | 4 | Aryeh Jason — Director | Purchase (P): 1,000 @ $2.45 | EDGAR |
| 2025-09-19 | 4 | Hochman David P — See Remarks, Director | Tax withholding (F): 40,355 @ $2.46 · Tax withholding (F): 3,283 @ $2.46 | EDGAR |
Recent 8-K events — Orchestra BioMed Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-02-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OBIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →